Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Multidisciplinary Delphi study on residual risk in patients with chronic kidney disease and type 2 diabetes mellitus Alberto Ortiz; Ana Cebrián; Alfonso Soto; Andrés Reyes; Jose Luis Górriz;

Hyperuricemia in patients with chronic kidney disease: When and what to treat? Marian Goicoechea; Rodrigo García-Marina;